GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » IMRIS Inc (GREY:IMRSQ) » Definitions » Net Cash per Share

IMRIS (IMRSQ) Net Cash per Share : $-0.78 (As of Dec. 2014)


View and export this data going back to 2010. Start your Free Trial

What is IMRIS Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). IMRIS's Net Cash per Share for the quarter that ended in Dec. 2014 was $-0.78.

The historical rank and industry rank for IMRIS's Net Cash per Share or its related term are showing as below:

IMRSQ's Price-to-Net-Cash is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 7.16
* Ranked among companies with meaningful Price-to-Net-Cash only.

IMRIS Net Cash per Share Historical Data

The historical data trend for IMRIS's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMRIS Net Cash per Share Chart

IMRIS Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only 0.88 0.46 -0.27 -0.96 -0.78

IMRIS Quarterly Data
Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.96 -0.84 -0.88 -0.79 -0.78

Competitive Comparison of IMRIS's Net Cash per Share

For the Medical Devices subindustry, IMRIS's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IMRIS's Price-to-Net-Cash Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IMRIS's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where IMRIS's Price-to-Net-Cash falls into.



IMRIS Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

IMRIS's Net Cash per Share for the fiscal year that ended in Dec. 2014 is calculated as

Net Cash per Share (A: Dec. 2014 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(5.002-53.694-0)/62.5943
=-0.78

IMRIS's Net Cash per Share for the quarter that ended in Dec. 2014 is calculated as

Net Cash per Share (Q: Dec. 2014 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(5.002-53.694-0)/62.5943
=-0.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IMRIS  (GREY:IMRSQ) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


IMRIS Net Cash per Share Related Terms

Thank you for viewing the detailed overview of IMRIS's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


IMRIS (IMRSQ) Business Description

Traded in Other Exchanges
N/A
Address
100-1370 Sony Place, Winnipeg, MB, CAN, R3T 1N5
IMRIS Inc designs, manufactures and markets Image-guided therapy systems that improves the effectiveness of therapy delivery. Its main product is the Visius surgical theater. The company provides its products to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular and cardiovascular markets. The firm is focused on bringing enhanced visualization to the point of therapy delivery and is spread across Canada, United States, Europe and the Middle East and Asia-Pacific.

IMRIS (IMRSQ) Headlines

No Headlines